NASDAQ: ELDNEledon Pharmaceuticals Inc Stock Ownership - Who owns Eledon Pharmaceuticals?
Insider buying vs selling
Have Eledon Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ELDN insiders and whales buy or sell their stock.
ELDN Shareholders
What type of owners hold Eledon Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Seth Loring Harrison | 10.53% | 8,124,773 | $32.09M | Insider |
| Bvf Inc | 8.15% | 6,293,282 | $24.86M | Institution |
| Erez Chimovits | 7.41% | 5,720,424 | $22.60M | Insider |
| Novartis Bioventures Ltd | 5.82% | 4,493,458 | $17.75M | Insider |
| Blackrock Inc | 5.68% | 4,382,245 | $17.31M | Institution |
| Apple Tree Partners II LP | 5.47% | 4,218,641 | $16.66M | Insider |
| Apple Tree Partners II Annex LP | 4.62% | 3,568,438 | $14.10M | Insider |
| Defilade Capital Management LP | 4.62% | 3,564,127 | $14.08M | Institution |
| Vanguard Capital Management LLC | 4.27% | 3,293,134 | $13.01M | Institution |
| Ensign Peak Advisors Inc | 3.19% | 2,464,919 | $9.74M | Institution |
ELDN vs Biotech Stocks
Eledon Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.